The global high content screening market is expected to reach USD 4,305,259.28 thousand by 2030 from USD 2,450,200.00 thousand in 2022, growing at a CAGR of 7.3% during the forecast period of 2023 to 2030.
Market Segmentation
Global High Content Screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Rest of Europe, Japan, China, India, South Korea, Australia, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, Bahrain, U.A.E., Kuwait, Oman, Qatar, Egypt, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.
Overview of Global High Content Screening Market Dynamics
- Driver
- Increasing drug discovery and development activities
- Restraint
- High cost associated with initial setup and maintenance
- Opportunity
- The growing number of Contract Research Organizations (CROs) providing HCS services
Market Players
Some of the major market players operating in the global high content screening market are:
- BD
- Merck KGaA
- Corning Incorporated
- Carl Zeiss AG
- Sartorius AG
- EVIDENT
- Zifo RnD Solutions
- Axxam S.p.A.
- Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Yokogawa Electric Corporation
- Sysmex Corporation
- Genedata AG
- De Novo Software
- Araceli Biosciences
- Miltenyi Biotec
- Aligned Genetics, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 60
- 1.1 OBJECTIVES OF THE STUDY 60
- 1.2 MARKET DEFINITION 60
- 1.3 OVERVIEW OF THE GLOBAL HIGH CONTENT SCREENING MARKET 60
- 1.4 LIMITATIONS 62
- 1.5 MARKETS COVERED 62
2 MARKET SEGMENTATION 66
- 2.1 MARKETS COVERED 66
- 2.2 GEOGRAPHICAL SCOPE 67
- 2.3 YEARS CONSIDERED FOR THE STUDY 68
- 2.4 CURRENCY AND PRICING 68
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 69
- 2.6 MULTIVARIATE MODELLING 72
- 2.7 PRODUCT TYPE LIFELINE CURVE 72
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 73
- 2.9 DBMR MARKET POSITION GRID 74
- 2.10 MARKET APPLICATION COVERAGE GRID 75
- 2.11 VENDOR SHARE ANALYSIS 76
- 2.12 SECONDARY SOURCES 77
- 2.13 ASSUMPTIONS 77
3 EXECUTIVE SUMMARY 78
4 PREMIUM INSIGHTS 80
- 4.1 PESTEL ANALYSIS 83
- 4.2 PORTER'S FIVE FORCES MODEL 84
5 GLOBAL HIGH CONTENT SCREENING MARKET: REGULATIONS 85
6 MARKET OVERVIEW, GLOBAL HIGH CONTENT SCREENING MARKET 87
- 6.1 DRIVERS 89
- 6.1.1 ADVANCEMENT IN IMAGING TECHNOLOGIES USED FOR HIGH CONTENT SCREENING 89
- 6.1.2 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS 89
- 6.1.3 INCREASING RESEARCH ACTIVITIES ASSOCIATED WITH THE USAGE OF HIGH CONTENT SCREENING 90
- 6.1.4 INCREASING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 91
- 6.2 RESTRAINTS 91
- 6.2.1 HIGH COST ASSOCIATED WITH INITIAL SETUP AND MAINTENANCE 91
- 6.2.2 COMPLEXITY ASSOCIATED WITH CELLULAR AND MOLECULAR SAMPLES 92
- 6.3 OPPORTUNITIES 93
- 6.3.1 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS (CROS) PROVIDING HCS SERVICES 93
- 6.3.2 RISING INTEGRATION WITH ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING IN DRUG DISCOVERY AND DEVELOPMENT 93
- 6.3.3 INCREASING GOVERNMENT INITIATIVE AND FUNDING IN R&D 94
- 6.4 CHALLENGES 94
- 6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE HCS 94
- 6.4.2 DATA SECURITY AND DATA MANAGEMENT PROBLEMS IN HCS 95
7 GLOBAL HIGH CONTENT SCREENING MARKET, BY PRODUCT TYPE 96
- 7.1 OVERVIEW 97
- 7.2 INSTRUMENTS 100
- 7.2.1 CELL IMAGING AND ANALYSIS SYSTEM 101
- 7.2.1.1 FIXED 101
- 7.2.1.2 MOBILE 101
- 7.2.2 HIGH-CONTENT AND SCREENING SYSTEM 101
- 7.2.2.1 FIXED 102
- 7.2.2.2 MOBILE 102
- 7.2.3 FLOW CYTOMETRY 102
- 7.2.4 INVITROGEN HCA ONSTAGE INCUBATOR 102
- 7.2.5 MICROPLATE MOVER 102
- 7.2.6 OTHERS 102
- 7.3 SOFTWARE 102
- 7.4 CONSUMABLES 103
- 7.4.1 REAGENTS & ASSAY KITS 104
- 7.4.2 MICROPLATES 104
- 7.4.3 OTHERS 104
- 7.5 ACCESSORIES 104
- 7.6 SERVICES 105
8 GLOBAL HIGH CONTENT SCREENING MARKET, BY APPLICATION 107
- 8.1 OVERVIEW 108
- 8.2 PRIMARY AND SECONDARY SCREENING 111
- 8.2.1 INSTRUMENTS 112
- 8.2.2 CONSUMABLES 112
- 8.2.3 ACCESSORIES 112
- 8.2.4 SERVICES 112
- 8.3 TARGET IDENTIFICATION AND VALIDATION 112
- 8.3.1 INSTRUMENTS 113
- 8.3.2 CONSUMABLES 113
- 8.3.3 ACCESSORIES 113
- 8.3.4 SERVICES 114
- 8.4 TOXICITY STUDIES 114
- 8.4.1 INSTRUMENTS 115
- 8.4.2 CONSUMABLES 115
- 8.4.3 ACCESSORIES 115
- 8.4.4 SERVICES 115
- 8.5 COMPOUND PROFILING 115
- 8.5.1 INSTRUMENTS 116
- 8.5.2 CONSUMABLES 116
- 8.5.3 ACCESSORIES 116
- 8.5.4 SERVICES 117
- 8.6 OTHER APPLICATIONS 117
9 GLOBAL HIGH CONTENT SCREENING MARKET, BY TECHNOLOGY 118
- 9.1 OVERVIEW 119
- 9.2 MICROSCOPY 122
- 9.3 FLOW CYTOMETRY 122
- 9.4 IMMUNOHISTOCHEMISTRY 123
- 9.5 MASS SPECTROMETRY 124
- 9.6 ELISA 125
- 9.7 WESTERN BLOTTING 126
- 9.8 OTHERS 126
- 9.8.1 3D CELL CULTURE MODEL 127
- 9.8.1.1 STEROIDS 128
- 9.8.1.2 ORGANOIDS 128
- 9.8.1.3 TISSUE ON A CHIP 128
- 9.8.2 EXTRACELLULAR MATRIX BASED SCAFFOLD 128
- 9.8.3 SYNTHETIC HYDROGEL AND SCAFFOLD 128
10 GLOBAL HIGH CONTENT SCREENING MARKET, BY END USER 129
- 10.1 OVERVIEW 130
- 10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 133
- 10.2.1 INSTRUMENTS 133
- 10.2.2 CONSUMABLES 134
- 10.2.3 ACCESSORIES 134
- 10.2.4 SERVICES 134
- 10.3 CONTRACT RESEARCH ORGANIZATIONS 134
- 10.3.1 INSTRUMENTS 135
- 10.3.2 CONSUMABLES 135
- 10.3.3 ACCESSORIES 135
- 10.3.4 SERVICES 135
- 10.4 LABORATORIES 136
- 10.4.1 INSTRUMENTS 137
- 10.4.2 CONSUMABLES 137
- 10.4.3 ACCESSORIES 137
- 10.4.4 SERVICES 137
- 10.5 ACADEMIC AND GOVERNMENT INSTITUTES 137
- 10.5.1 INSTRUMENTS 138
- 10.5.2 CONSUMABLES 138
- 10.5.3 ACCESSORIES 138
- 10.5.4 SERVICES 138
- 10.6 OTHERS 139
11 GLOBAL HIGH CONTENT SCREENING MARKET, BY DISTRIBUTION CHANNEL 140
- 11.1 OVERVIEW 141
- 11.2 DIRECT TENDERS 144
- 11.3 RETAIL SALES 144
12 GLOBAL HIGH CONTENT SCREENING MARKET, BY REGION 146
- 12.1 OVERVIEW 147
- 12.2 NORTH AMERICA 152
- 12.2.1 U.S. 163
- 12.2.2 CANADA 170
- 12.2.3 MEXICO 177
- 12.3 EUROPE 184
- 12.3.1 GERMANY 196
- 12.3.2 FRANCE 203
- 12.3.3 U.K. 210
- 12.3.4 ITALY 217
- 12.3.5 SPAIN 224
- 12.3.6 RUSSIA 231
- 12.3.7 TURKEY 238
- 12.3.8 BELGIUM 245
- 12.3.9 DENMARK 252
- 12.3.10 NETHERLANDS 259
- 12.3.11 SWITZERLAND 266
- 12.3.12 SWEDEN 273
- 12.3.13 POLAND 280
- 12.3.14 NORWAY 287
- 12.3.15 FINLAND 294
- 12.3.16 REST OF EUROPE 301
- 12.4 ASIA-PACIFIC 302
- 12.4.1 JAPAN 314
- 12.4.2 CHINA 321
- 12.4.3 INDIA 328
- 12.4.4 SOUTH KOREA 335
- 12.4.5 AUSTRALIA 342
- 12.4.6 NEW ZEALAND 349
- 12.4.7 SINGAPORE 356
- 12.4.8 THAILAND 363
- 12.4.9 MALAYSIA 370
- 12.4.10 VIETNAM 377
- 12.4.11 TAIWAN 384
- 12.4.12 INDONESIA 391
- 12.4.13 PHILIPPINES 398
- 12.4.14 REST OF ASIA-PACIFIC 405
- 12.5 SOUTH AMERICA 406
- 12.5.1 BRAZIL 417
- 12.5.2 ARGENTINA 424
- 12.5.3 REST OF SOUTH AMERICA 431
- 12.6 MIDDLE EAST AND AFRICA 432
- 12.6.1 SOUTH AFRICA 443
- 12.6.2 SAUDI ARABIA 450
- 12.6.3 BAHRAIN 457
- 12.6.4 U.A.E 464
- 12.6.5 KUWAIT 471
- 12.6.6 OMAN 478
- 12.6.7 QATAR 485
- 12.6.8 EGYPT 492
- 12.6.9 ISRAEL 499
- 12.6.10 REST OF MIDDLE EAST AND AFRICA 506
13 GLOBAL HIGH CONTENT SCREENING MARKET, COMPANY LANDSCAPE 507
- 13.1 COMPANY SHARE ANALYSIS: GLOBAL 507
- 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 508
- 13.3 COMPANY SHARE ANALYSIS: EUROPE 509
- 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 510
14 GLOBAL CONTENT SCREENING MARKET, COMPANY PROFILES 511
- 14.1 THERMO FISHER SCIENTIFIC INC. (2022) 511
- 14.1.1 COMPANY SNAPSHOT 511
- 14.1.2 REVENUE ANALYSIS 511
- 14.1.3 COMPANY SHARE ANALYSIS 512
- 14.1.4 PRODUCT PORTFOLIO 512
- 14.1.5 RECENT DEVELOPMENT 512
- 14.2 BD 513
- 14.2.1 COMPANY SNAPSHOT 513
- 14.2.2 REVENUE ANALYSIS 513
- 14.2.3 COMPANY SHARE ANALYSIS 514
- 14.2.4 PRODUCT PORTFOLIO 514
- 14.2.5 RECENT DEVELOPMENTS 514
- 14.3 PERKINELMER INC. (2022) 515
- 14.3.1 COMPANY SNAPSHOT 515
- 14.3.2 REVENUE ANALYSIS 515
- 14.3.3 COMPANY SHARE ANALYSIS 516
- 14.3.4 PRODUCT PORTFOLIO 516
- 14.3.5 RECENT DEVELOPMENTS 517
- 14.4 YOKOGAWA ELECTRIC CORPORATION (2022) 518
- 14.4.1 COMPANY SNAPSHOT 518
- 14.4.2 REVENUE ANALYSIS 518
- 14.4.3 COMPANY SHARE ANALYSIS 519
- 14.4.4 PRODUCT PORTFOLIO 519
- 14.4.5 RECENT DEVELOPMENT 519
- 14.5 MOLECULAR DEVICES, LLC. (A SUBSIDIARY OF DANAHER CORPORATION) 520
- 14.5.1 COMPANY SNAPSHOT 520
- 14.5.2 REVENUE ANALYSIS 520
- 14.5.3 COMPANY SHARE ANALYSIS 521
- 14.5.4 PRODUCT PORTFOLIO 521
- 14.5.5 RECENT DEVELOPMENT 522
- 14.6 AGILENT TECHNOLOGIES, INC. (2022) 523
- 14.6.1 COMPANY SNAPSHOT 523
- 14.6.2 REVENUE ANALYSIS 523
- 14.6.3 PRODUCT PORTFOLIO 524
- 14.6.4 RECENT DEVELOPMENT 524
- 14.7 ALIGNED GENETICS, INC. (2022) 525
- 14.7.1 COMPANY SNAPSHOT 525
- 14.7.2 REVENUE ANALYSIS 525
- 14.7.3 PRODUCT PORTFOLIO 526
- 14.7.4 RECENT DEVELOPMENT 526
- 14.8 ARACELI BIOSCIENCES 527
- 14.8.1 COMPANY SNAPSHOT 527
- 14.8.2 PRODUCT PORTFOLIO 527
- 14.8.3 RECENT DEVELOPMENT 527
- 14.9 AXXAM S.P.A 528
- 14.9.1 COMPANY SNAPSHOT 528
- 14.9.2 PRODUCT PORTFOLIO 528
- 14.9.3 RECENT DEVELOPMENT 528
- 14.10 BIO-RAD LABORATORIES, INC. (2022) 529
- 14.10.1 COMPANY SNAPSHOT 529
- 14.10.2 REVENUE ANALYSIS 529
- 14.10.3 PRODUCT PORTFOLIO 530
- 14.10.4 RECENT DEVELOPMENTS 530
- 14.11 CARL ZEISS AG 531
- 14.11.1 COMPANY SNAPSHOT 531
- 14.11.2 REVENUE ANALYSIS 531
- 14.11.3 PRODUCT PORTFOLIO 532
- 14.11.4 RECENT DEVELOPMENT 532
- 14.12 CORNING INCORPORATED 533
- 14.12.1 COMPANY SNAPSHOT 533
- 14.12.2 REVENUE ANALYSIS 533
- 14.12.3 PRODUCT PORTFOLIO 534
- 14.12.4 RECENT DEVELOPMENT 534
- 14.13 DE NOVO SOFTWARE 535
- 14.13.1 COMPANY SNAPSHOT 535
- 14.13.2 PRODUCT PORTFOLIO 535
- 14.13.3 RECENT DEVELOPMENTS 535